FDA-Approved Drug Restores Hair in Patients with Alopecia Areata

“We are tremendously grateful for the research funding from Locks of Love. Particularly during these challenging times for NIH funding, the support of Locks of Love was absolutely crucial to enable us to conduct these groundbreaking studies. 

Many people know that Locks of Love donates hairpieces to children suffering from medical hair loss—most often caused by alopecia areata. 

But its support of research is equally important. Our goal as scientists is to find a treatment, and eventually cure, for this disease.” Dr. Angela Christiano

Congratulations to Drs. Angela Christiano (right), Raphael Clynes (center), and Julian Mackay-Wiggan (left), and their team at Columbia University Medical Center for their success with an FDA approved drug that has restored hair growth in a small number of patients.

In 2011, Locks of Love continued its initiative to fund research into alopecia areata by awarding Columbia University’s Department of Dermatology with a three-year commitment of $1 Million in support of their genetics research of alopecia areata. In November, 2013, Locks of Love extended its commitment with an additional $1.5 Million to support these specific clinical trials.

View the CUMC press release.

read the post